Search This Blog

Wednesday, August 7, 2019

ADVANZ PHARMA EPS misses by $0.45, beats on revenue

ADVANZ PHARMA (OTCPK:CXRXF): Q2 GAAP EPS of -$0.90 misses by $0.45.
Revenue of $131.08M (-6.0% Y/Y) beats by $4.08M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)